Intelligent use and clinical benefits of electronic health records in rheumatoid arthritis

Expert Review of Clinical Immunology

Volumn 11, Issue 3, 2015, Pages 329-337

  Carroll, Robert J ^a   Eyler, Anne E ^b   Denny, Joshua C ^a,c  

^a VANDERBILT UNIVERSITY   (United States)

^b NorthCrest Rheumatology   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

clinical decision support systems; electronic health records; genomics; pharmacogenetics; rheumatoid arthritis

Indexed keywords

ACCURACY; ELECTRONIC MEDICAL RECORD; GENOMICS; HUMAN; MEDICAL INFORMATICS; MEDICAL INFORMATION SYSTEM; MEDICAL PRACTICE; MEDICAL RESEARCH; PATIENT CARE; PHARMACOGENOMICS; REVIEW; RHEUMATOID ARTHRITIS; DECISION SUPPORT SYSTEM; ELECTRONIC HEALTH RECORD;

ARTHRITIS, RHEUMATOID; BIOMEDICAL RESEARCH; DECISION SUPPORT TECHNIQUES; ELECTRONIC HEALTH RECORDS; GENOMICS; HUMANS; MEDICAL INFORMATICS;

EID: 84923326346     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2015.1009895     Document Type: Review

References (73)

1. Greenes RA, Pappalardo AN, Marble CW, Barnett GO. Design and implementation of a clinical data management system. Comput Biomed Res 1969;2(5):469-85
2. McDonald CJ. Protocol-based computer reminders, the quality of care and the non-perfectibility of man. N Engl J Med 1976;295(24):1351-5
3. Shortliffe EH, Buchanan BG. A model of inexact reasoning in medicine. Math Biosci 1975;23(3-4):351-79
4. Nuckols TK, Smith-Spangler C, Morton SC, et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-Analysis. Syst Rev 2014;3(1):56
5. King J, Patel V, Jamoom EW, Furukawa MF. Clinical benefits of electronic health record use: national findings. Health Serv Res 2014;49(1 Pt 2): 392-404
6. Wang SJ, Middleton B, Prosser LA, et al. A cost-benefit analysis of electronic medical records in primary care. Am J Med 2003; 114(5):397-403
7. Han YY, Carcillo JA, Venkataraman ST, et al. Unexpected increased mortality after implementation of a commercially sold computerized physician order entry system. Pediatrics 2005;116(6):1506-12
8. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA 2005;293(10):1197-203
9. Wang X, Hripcsak G, Markatou M, Friedman C. Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. J Am Med Inform Assoc JAMIA 2009;16(3):328-37
10. Köpcke F, Lubgan D, Fietkau R, et al. Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data. BMC Med Inform Decis Mak 2013;13:134
11. McCarty CA, Chisholm RL, Chute CG, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011;4:13
12. Kohane IS. Using electronic health records to drive discovery in disease genomics. Nat Rev Genet 2011;12(6):417-28
13. Jha AK, DesRoches CM, Campbell EG, et al. Use of electronic health records in U.S. hospitals. N Engl J Med 2009;360(16): 1628-38
14. Pulley JM, Denny JC, Peterson JF, et al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther 2012;92(1):87-95
15. Roberts GW, Farmer CJ, Cheney PC, et al. Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting. J Am Med Inform Assoc JAMIA 2010;17(3):308-12
16. Phansalkar S, Desai AA, Bell D, et al. High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc JAMIA 2012;19(5):735-43
17. Leung AA, Keohane C, Amato M, et al. Impact of vendor computerized physician order entry in community hospitals. J Gen Intern Med 2012;27(7):801-7
18. Rha B, Burrer S, Park S, et al. Emergency department visit data for rapid detection and monitoring of norovirus activity, United States. Emerg Infect Dis 2013;19(8): 1214-21
19. de Vries-Bouwstra J, Cessie SL, Allaart C, et al. Using predicted disease outcome to provide differentiated treatment of early rheumatoid arthritis. J Rheumatol 2006; 33(9):1747-53
20. Fricton J, Rindal DB, Rush W, et al. The effect of electronic health records on the use of clinical care guidelines for patients with medically complex conditions. J Am Dent Assoc 1939;142(10):1133-42
21. Matsui T, Tohma S. Support system for medical examination and treatment and for clinical research in rheumatic diseases. Nihon Rinsho Jpn J Clin Med 2005; 63(Suppl 1):699-705
22. Kolarz G, Adlassnig KP, Bögl K. RHEUMexpert: a documentation and expert system for rheumatic diseases. Wien Med Wochenschr 1946;149(19-20):572-4
23. Leeb BF. Hotel-based rheumatology, and more. J Rheumatol 2009;36(2):455-5
24. Palmer D, El Miedany Y. EROMIA in inflammatory arthritis: the next step in standard practice. Br J Nurs Mark Allen Publ 2010;19(1):42-6
25. Fransen J, Twisk JWR, Creemers MCW, Van Riel PLCM. Design and analysis of a randomized controlled trial testing the effects of clinical decision support on the management of rheumatoid arthritis. Arthritis Care Res 2004;51(1):124-7
26. Van der Wilt GJ, Groenewoud H, van Riel P. Bridging the gap between aggregate data and individual patient management: a Bayesian approach. Int J Technol Assess Health Care 2011;27(2): 133-8
27. Dahlström O, Timpka T, Hass U, et al. A simple method for heuristic modeling of expert knowledge in chronic disease: identification of prognostic subgroups in rheumatology. Stud Health Technol Inform 2008;136:157-62
28. Williams CA, Mosley-Williams AD, Overhage JM. Arthritis quality indicators for the Veterans administration: implications for electronic data collection, storage format, quality assessment, and clinical decision support. AMIA Annu Symp Proc 2007; 806-10
29. Adhikesavan LG, Newman ED, Diehl MP, et al. American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record. Arthritis Rheum 2008;59(12):1705-12
30. Agnew-Blais J, Coblyn JS, Katz JN, et al. Measuring quality of care for rheumatic diseases using an electronic medical record. Ann Rheum Dis 2009;68(5):680-4
31. Prevoo ML, van Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38(1):44-8
32. Collier DS, Kay J, Estey G, et al. A rheumatology-specific informatics-based application with a disease activity calculator. Arthritis Rheum 2009;61(4):488-94
33. Collier DS, Grant RW, Estey G, et al. Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record-based disease activity calculator. Arthritis Rheum 2009;61(4): 495-500
34. El Miedany Y, El Gaafary M, Palmer D. Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: a pilot study. Rheumatol Int 2012;32(10):3061-8
35. Botsis T, Hartvigsen G, Chen F, Weng C. Secondary use of EHR: data quality issues and informatics opportunities. AMIA Summits Transl Sci Proc 2010;2010: 1-5
36. Pakhomov S, Weston SA, Jacobsen SJ, et al. Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care 2007; 13(6 Part 1):281-8
37. Roden D, Xu H, Denny J, Wilke R. Electronic medical records as a tool in clinical pharmacology: opportunities and challenges. Clin Pharmacol Ther 2012; 91(6):1083-6
38. Chute CG, Pathak J, Savova GK, et al. The SHARPn project on secondary use of electronic medical record data: progress, plans, and possibilities. AMIA Annu Symp Proc 2011;2011:248-56
39. Wei W-Q, Leibson CL, Ransom JE, et al. Impact of data fragmentation across healthcare centers on the accuracy of a high-Throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus. J Am Med Inform Assoc JAMIA 2012;19(2):219-24
40. Denny JC, Bastarache L, Ritchie MD, et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol 2013;31(12): 1102-10
41. Web. PharmacoGenomic discovery and replication in very large patient POpulations (PGPop). Available from: http://pgpop. mc.vanderbilt.edu/labkey/project/PGPop/.begin.view?
42. Daugherty SE, Wahba S, Fleurence R. Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research. J Am Med Inform Assoc JAMIA 2014;21(4):583-6
43. Coorevits P, Sundgren M, Klein GO, et al. Electronic health records: new opportunities for clinical research. J Intern Med 2013; 274(6):547-60
44. Carroll RJ, Thompson WK, Eyler AE, et al. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc JAMIA 2012;19(e1):e162-9
45. Ng B, Aslam F, Petersen NJ, et al. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study. Arthritis Care Res 2012;64(10):1490-6
46. Liao KP, Cai T, Gainer V, et al. Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res 2010;62(8):1120-7
47. Ritchie MD, Denny JC, Crawford DC, et al. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet 2010;86(4): 560-72
48. Carroll RJ, Eyler AE, Denny JC. Naïve electronic health record phenotype identification for rheumatoid arthritis. AMIA Annu Symp Proc AMIA Symp AMIA Symp 2011;2011:189-96
49. Cortes C, Vapnik V. Support-vector networks. Mach Learn 1995;20(3):273-97
50. Nicholson A, Ford E, Davies KA, et al. Optimising use of electronic health records to describe the presentation of rheumatoid arthritis in primary care: a strategy for developing code lists. PLoS One 2013;8(2): e54878
51. Ford E, Nicholson A, Koeling R, et al. Optimising the use of electronic health records to estimate the incidence of rheumatoid arthritis in primary care: what information is hidden in free text?. BMC Med Res Methodol 2013;13(1):105
52. Liao KP, Kurreeman F, Li G, et al. Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. Arthritis Rheum 2013;65(3): 571-81
53. Lin C, Karlson EW, Canhao H, et al. Automatic prediction of rheumatoid arthritis disease activity from the electronic medical records. PLoS One 2013;8(8):e69932
54. Tymms K, Zochling J, Scott J, et al. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity. Arthritis Care Res 2014;66(2):190-6
55. Schmajuk G, Miao Y, Yazdany J, et al. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Arthritis Care Res 2014;66(8):1159-66
56. Denny JC, Ritchie MD, Basford MA, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 2010;26(9): 1205-10
57. Roden D, Pulley J, Basford M, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 2008;84(3): 362-9
58. Kullo IJ, Ding K, Jouni H, et al. A genome-wide association study of red blood cell traits using the electronic medical record. PLoS One 2010;5:9
59. Kullo IJ, Fan J, Pathak J, et al. Leveraging informatics for genetic studies: use of the electronic medical record to enable a genome-wide association study of peripheral arterial disease. J Am Med Inform Assoc JAMIA 2010;17(5):568-74
60. Web. Kaiser Permanente, UCSF Scientists Complete NIH-Funded Genomics Project Involving 100, 000 People. Internet Available from: www.dor.kaiser.org/external/.news/press-releases/Kaiser-Permanente,-UCSF-Scientists-Complete-NIHFunded- Genomics-Projectinvolving-100, 000-People/
61. Kurreeman F, Liao K, Chibnik L, et al. Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am J Hum Genet 2011; 88(1):57-69
62. Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014; 506(7488):376-81
63. Wilke R, Xu H, Denny J, et al. The emerging role of electronic medical records in pharmacogenomics. Clin Pharmacol Ther 2011;89(3):379-86
64. Peterson JF, Bowton E, Field JR, et al. Electronic health record design and implementation for pharmacogenomics: a local perspective. Genet Med Off J Am Coll Med Genet 2013;15(10):833-41
65. Van Driest S, Shi Y, Bowton EA, et al. Clinically actionable genotypes among 10, 000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther 2014;95(4):423-31
66. Hicks JK, Crews KR, Hoffman JM, et al. A clinician-driven automated system for integration of pharmacogenetic consults into an electronic medical record. Clin Pharmacol Ther 2012;92(5):563-6
67. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349(5):474-85
68. Njoku DB. Drug-induced hepatotoxicity: metabolic, genetic and immunological basis. Int J Mol Sci 2014;15(4):6990-7003
69. Marquez A, Ferreiro-Iglesias A, Davila-Fajardo CL, et al. Lack of validation of genetic variants associated with anti-Tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-Analysis. Arthritis Res Ther 2014; 16(2):R66
70. Lin C, Canhao H, Miller T, et al. Feature Engineering and Selection for Rheumatoid Arthritis Disease Activity Classification Using Electronic Medical Records. In: Proceedings of International Conference of Machine Learning (ICML) Workshop on Machine Learning for Clinical Data. 2012
71. Mandl KD, Mandel JC, Murphy SN, et al. The SMART Platform: early experience enabling substitutable applications for electronic health records. J Am Med Inform Assoc JAMIA 2012;19(4):597-603
72. Swanton C. My cancer genome: a unified genomics and clinical trial portal. Lancet Oncol 2012;13(7):668-9
73. Sciencedirect. Available from: www. sciencedirect.com/science/journal/00029297